Flagging this for incorrect information. It was initiated in 2021. So 2021, 2022, 2023. I count that we are on the third year.
“Vin”- might want to check your spelling and grammar. Just take a look, buddy.
Thanks for the link to the clinical trials website. Actually, look at the history of revisions. You can see that it was planned to complete in 2022, but that has been pushed back a year to December 2023. Why? Cause no one wants to give their kid this drug.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.